Analysis reportAll specifications met
Retatrutide 20mg
Peptide Stock ref. PSV-2609-RT20-04
Purity99.83%HPLC
Content per vial20.283 mg101.4% of 20 mg label claim
IdentityConfirmedHPLC
Test results
| Test | Specification | Result | Outcome |
|---|---|---|---|
| Identity | Retatrutide | Conforms | Pass |
| Purity (HPLC) | > 98.0% | 99.826% | Pass |
| Quantity per vial | Measured | 20.283 mg (101.4% of claim) | Reported |
About this report
- Sample received by the lab 21 September 2026; report issued 26 September 2026.
- Results relate to the sample tested. For laboratory research use only.